Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;32(1):72-80.
doi: 10.1080/13506129.2024.2448440. Epub 2025 Jan 8.

Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damage

Brian C Netzel  1 , M Cristine Charlesworth  2 , Kenneth L Johnson  2 , Amy J French  2 , Angela Dispenzieri  3 , Joseph J Maleszewski  4 , Ellen D McPhail  4 , Martha Grogan  5 , Margaret M Redfield  5 , Megan Weivoda  3 , Eli Muchtar  3 , Morie A Gertz  3 , Shaji K Kumar  3 , Pinaki Misra  6 , Julie Vrana  4 , Jason Theis  4 , Suzanne R Hayman  3 , Marina Ramirez-Alvarado  6 , Surendra Dasari  7 , Taxiarchis Kourelis  3
Affiliations

Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damage

Brian C Netzel et al. Amyloid. 2025 Mar.

Abstract

Background: Cardiac AL and ATTR are potentially fatal cardiomyopathies. Current therapies do not address mechanisms of tissue dysfunction because these remain unknown. Our prior work focused on the amyloid plaque proteome, which may not capture tissue-wide proteomic alterations.

Objectives: To evaluate mechanisms of tissue dysfunction in cardiac AL and ATTR using a full biopsy tissue proteomics approach.

Methods: We performed proteomics analysis on 76 ATTR and 27 AL diagnostic endomyocardial biopsies.

Results: Stage-3 AL patients exhibited increased coagulation, extracellular matrix remodelling (ECM), epithelial-to-mesenchymal transition (EMT), complement activation, hypoxia, and clathrin-mediated endocytosis pathways vs. stages-1/2, with decreased healthy cardiac metabolism. In stages-2 and 3 ATTR, immunoglobulin proteins, complement, and keratinisation pathways were increased compared to stage-1. Unsupervised analyses identified an ATTR group with worse survival characterised by upregulated complement and downregulated metabolic pathways. Compared to ATTR, AL had higher clathrin-mediated endocytosis, mRNA splicing, and ribosomal proteins, while ATTR had higher complement levels.

Conclusions: This study identifies known processes dysregulated in heart failure with preserved ejection fraction as well as novel pathways responsible for tissue damage. Our results support an immune-mediated mechanism of tissue toxicity in cardiac amyloidosis, especially among patients with worse outcomes.

Keywords: Amyloidosis; complement; light chain; proteomics; tissue damage; transthyretin.

PubMed Disclaimer

References

    1. Maurer MS, Schwartz JH, Gundapaneni B et al. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med 2018;379:1007–1016. - PubMed
    1. Marin-Argany M, Lin Y, Misra P et al. Cell Damage in Light Chain Amyloidosis: Fibril internalization, toxicity and cell-mediated seeding. J Biol Chem 2016;291:19813–25. - PMC - PubMed
    1. Guan J, Mishra S, Qiu Y et al. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. EMBO Mol Med 2014;6:1493–507. - PMC - PubMed
    1. Shi J, Guan J, Jiang B et al. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci U S A 2010;107:4188–93. - PMC - PubMed
    1. Sartiani L, Bucciantini M, Spinelli V et al. Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes. Biophys J 2016;111:2024–2038. - PMC - PubMed

Supplementary concepts